Yoga Exercise in Series Decreased Soluble Fms-like Tyrosine Kinase-1 (SFLT-1) Level Among the High-risk Preeclampsia Mother
Main Article Content
Abstract
An essential part of the pathophysiology of PE is played by SFlt-1. According to earlier studies, sFlt-1 expression starts to rise five weeks prior to conception and increases dramatically in the placenta preeclampsia at 11 weeks of pregnancy. For mothers who are at high risk, exercise in series can avoid preeclampsia. The purpose of this study is to examine how yoga practice affects blood sFLT-1 levels in moms who are at high risk of developing preeclampsia. Materials and methods: Forty-six high-risk mothers with preeclampsia, aged 9-16 weeks pregnant randomly grouped into control groups and yoga exercises. All subjects get standard treatment for preeclampsia. The yoga sports group also performed 20 sets of yoga under supervision. SFLT-1 levels were measured before and after the treatment course. Results: In the yoga group the sFLT1 levels differed significantly (p=0.010), before (1.13 ± 0.42 ng/ml) and after (0.94 ±0.38 ng/mL) the treatment program. In the control group the levels of sFTL-1 also differed signally (p = 0.049). before (0.85 ± 0.029 ng/ ml) and following (1.01 ± 0,38 ng / ml) the therapy program. Conclusion: Yoga consistently lowers serum sFLT-1 levels in mothers at high risk of preeclampsia.
Downloads
Article Details
References
Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Vol. 15, Nature Reviews Nephrology. Nature Publishing Group; 2019;15(5):275-289. doi: 10.1038/s41581-019-0119-6.
Sulistyowati S, Irawan D, Edwin E, Departemen Obstetri dan Ginekologi S, Kedokteran F. VEGF 121 Rekombinan Dapat Memperbaiki Endoteliosis Gromerular pada Mencit Bunting Model Preeeklampsia VEGF 121 Recombinant Repairs Glomerular Endotheliosis in Preeclampsia Mice Model. 2016;24(1):19-24. doi.org/10.20473/mog. v24i1.2758.
Maharrani T, Santoso S, Indrawan IWA, Irawati D, Sukesi. The effect of ethanol extracts black cumin (Nigella sativa) on renal ET-1 and eNOS expression mice preeclampsia model. Indian Journal of Forensic Medicine and Toxicology. 2019;13(4):1712–6. doi: 10.5958/0973-9130.2019.00555.3.
Powe CE, Levine RJ, Karumanchi SA, Israel B. Preeclampsia, a disease of the maternal endothelium: the role of anti-angiogenic factors and implications for later cardiovascular disease Clinical Features and Epidemiology of Preeclampsia. Circulation. 2011; 21;123(24):10.1161/CIRCULATIONAHA.109.853127.doi:10.1161/CIRCULATIONAHA .109.853127.
Lyall F, Robson SC, Bulmer JN. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction. Hypertension. 2013;62(6):1046-54. doi: 10.1161/HYPERTENSIONAHA.113.01892.
Weel IC, Baergen RN, Romão-Veiga M, Borges VT, Ribeiro VR, Witkin SS, et al. Association between placental lesions, cytokines and angiogenic factors in pregnant women with preeclampsia. PLoS One. 2016;11(6): e0157584. doi: 10.1371/journal.pone.0157584
Hecht JL, Ordi J, Carrilho C, Ismail MR, Zsengeller ZK, Karumanchi SA, et al. The pathology of eclampsia: An autopsy series. Vol. 36, Hypertension in Pregnancy. 2017;36(3):259-268. doi: 10.1080/10641955.2017.1329430.
Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010;122(5):478–87. doi: 10.1161/ CIRCULATIONAHA.109.895458.
Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. New England Journal of Medicine. 2017;377(7):613–622. doi: 10.1056/NEJMoa1704559.
Karthiga K, Pal GK, Dasari P, Nanda N, Velkumary S, Chinnakali P, et al. Effects of yoga on cardiometabolic risks and fetomaternal outcomes are associated with serum nitric oxide in gestational hypertension: a randomized control trial. Sci Rep. 2022;12(1). 11732. doi: 10.1038/s41598-022-15216-4.
Rakhmawati N, Wulandari Y, Program Sarjana K, Kesehatan I. Faktor-faktor yang mempengaruhi pre eklamsia pada ibu hamil di Puskesmas Banyuanyar Surakarta. The Factors Influencing Pre Eclamsia in Pregnant Women at Puskesmas (Public Health Center) In Banyuanyar Surakarta. Jurnal Kesehatan Madani Medika. 2021;12(01):59–67. doi: 10.36569/jmm. v12i1.152
Malhotra AS, Goel P, Chaudhary A, Kochhar S, Kaur G, Bhagat A. Serial profile of flow-mediated dilatation in primigravida for prediction of preeclampsia and gestational hypertension. Hypertens Pregnancy. 2018 Oct 2;37(4):212–9. doi: 10.1080 /10641955.2018.1524480.
Kementerian Kesehatan RI. Buku kesehatan ibu dan anak.2023. ISBN 978-623-301-149-5.
Lemeshow P, David W, Janelle K, Stephen K. Adequancy of sample size in health studies. New York: Jonh Willey, Sons; 1990.
Sharma K, Maity K, Goel S, Kanwar S, Anand A. Common Yoga Protocol Increases Peripheral Blood CD34+ Cells: An Open-Label Single-Arm Exploratory Trial. J Multidiscip Healthc. 2023; 16:1721–36. doi: 10.2147/JMDH.S377869.
Mamlukah M, Kumalasari I, Setiadi R. Antenatal Yoga and Murottal Al-Quran Therapy Decreasing Anxiety and Blood Pressure of Preeclampsia Risk Women. Media Kesehatan Masyarakat Indonesia. 2020;16(4):410–20. doi:10.30597/mkmi. v16i4.9094.
Fernández Alba JJ, Mesa Páez C, Vilar Sánchez Á, Soto Pazos E, González Macías M del C, Serrano Negro E, et al. Sobrepeso y obesidad como factores de riesgo de los estados hipertensivos del embarazo: estudio de cohortes retrospectivo. Nutr Hosp. 2018;35(4):874. doi: 10.20960/nh.1702.
Bodnar LM, Ness RB, Markovic N, Roberts JM. The Risk of Preeclampsia Rises with Increasing Prepregnancy Body Mass Index. Ann Epidemiol. 2005 Aug;15(7):475–82. doi: 10.1016/j.annepidem.2004.12.008.
Leaños-Miranda A, Graciela Nolasco-Leaños A, Ismael Carrillo-Juárez R, José Molina-Pérez C, Janet Sillas-Pardo L, Manuel Jiménez-Trejo L, et al. Usefulness of the sFlt-1/PlGF (Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor) Ratio in Diagnosis or Misdiagnosis in Women with Clinical Diagnosis of Preeclampsia. Hypertension. 2020 Sep 1;76(3):892–900. doi: 10.1161/HYPERTENSIONAHA.120.15552.
Jena MK, Sharma NR, Petitt M, Maulik D, Nayak NR. Pathogenesis of preeclampsia and therapeutic approaches targeting the placenta. Biomolecules. 2020. 10(6):953. doi: 10.3390/biom10060953.